Powered by

Advertisment
Home Insight

[Funding alert] Marketing Startup SingleInterface Secures $30 Mn Led by Asia Partners

By Viestories
New Update
Asia Partners financed a $30 million first external investment round for SingleInterface, a firm providing marketing tools.

Asia Partners financed a $30 million first external investment round for SingleInterface, a firm providing marketing tools.

PayPal Ventures also took part in the funding round.

Tarun Sobhani, the company's cofounder and chief executive officer, told ET that the Gurgaon-based business would utilise the funds to develop products and grow throughout Southeast Asia as well as in more recent areas like Japan and Australia.

Read also - [Funding alert] AI Startup SiftHub Secures $5.5M Seed Funding Led by Matrix Partners India & Blume Ventures

From managing listings and reviews across search, social platforms, maps, apps, voice assistants, local directories, and more, to creating and overseeing hyperlocal targeted advertising campaigns at scale and effectively facilitating hyperlocal e-commerce through the publication of store-level inventory & transaction capabilities across digital channels, SingleInterface has developed into everything hyperlocal.

About SingleInterface

With over 400 multi-location brands spanning industries such as food and beverage, retail, automotive, telecommunications, banking, and education, SingleInterface currently serves customers across Asia and the Middle East. 

Sobhani and Harish Bahl launched and nurtured SingleInterface in 2015 as a subsidiary of Smile Group. In addition, Bahl founded Smile Group.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.

Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.

Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.